222 related articles for article (PubMed ID: 25482743)
21. The current treatment landscape: other fungal diseases (cryptococcosis, fusariosis and mucormycosis).
Lortholary O; Fernández-Ruiz M; Perfect JR
J Antimicrob Chemother; 2016 Nov; 71(suppl 2):ii31-ii36. PubMed ID: 27880667
[TBL] [Abstract][Full Text] [Related]
22. EPICO 2.0 PROJECT. Development of educational therapeutic recommendations using the DELPHI technique on invasive candidiasis in critically ill adult patients in special situations.
Zaragoza R; Ferrer R; Maseda E; Llinares P; Rodríguez A;
Rev Esp Quimioter; 2014 Sep; 27(3):196-212. PubMed ID: 25229375
[TBL] [Abstract][Full Text] [Related]
23. Antifungal prophylaxis during treatment for haematological malignancies: are we there yet?
Rogers TR; Slavin MA; Donnelly JP
Br J Haematol; 2011 Jun; 153(6):681-97. PubMed ID: 21504422
[TBL] [Abstract][Full Text] [Related]
24. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.
Rex JH; Walsh TJ; Sobel JD; Filler SG; Pappas PG; Dismukes WE; Edwards JE
Clin Infect Dis; 2000 Apr; 30(4):662-78. PubMed ID: 10770728
[TBL] [Abstract][Full Text] [Related]
25. Consensus guidelines for the diagnosis and management of invasive candidiasis in haematology, oncology and intensive care settings, 2021.
Keighley C; Cooley L; Morris AJ; Ritchie D; Clark JE; Boan P; Worth LJ;
Intern Med J; 2021 Nov; 51 Suppl 7():89-117. PubMed ID: 34937142
[TBL] [Abstract][Full Text] [Related]
26. Candida infections in non-neutropenic children after the neonatal period.
Hacimustafaoglu M; Celebi S
Expert Rev Anti Infect Ther; 2011 Oct; 9(10):923-40. PubMed ID: 21973304
[TBL] [Abstract][Full Text] [Related]
27. [Invasive fungal infection in critically ill patients].
Garnacho-Montero J; Díaz-Martín A; Ruiz-Pérez De Piappón M; García-Cabrera E
Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):338-43. PubMed ID: 22503211
[TBL] [Abstract][Full Text] [Related]
28. Invasive fungal infections in critically ill children: epidemiology, risk factors and antifungal drugs.
Hon KLE; Chan VP; Leung AK; Leung KKY; Hui WF
Drugs Context; 2024; 13():. PubMed ID: 38915918
[TBL] [Abstract][Full Text] [Related]
29. Management of candidaemia and invasive candidiasis in critically ill patients.
Chahoud J; Kanafani ZA; Kanj SS
Int J Antimicrob Agents; 2013 Jun; 42 Suppl():S29-35. PubMed ID: 23664579
[TBL] [Abstract][Full Text] [Related]
30. Yeast Infections in Solid Organ Transplantation.
Taimur S
Infect Dis Clin North Am; 2018 Sep; 32(3):651-666. PubMed ID: 30146028
[TBL] [Abstract][Full Text] [Related]
31. [Épico project: Development of educational recommendations using the DELPHI technique on invasive candidiasis in non-neutropenic critically ill adult patients. Grupo Proyecto Épico].
Zaragoza R; Llinares P; Maseda E; Ferrer R; Rodríguez A;
Rev Iberoam Micol; 2013; 30(3 Suppl 1):135-49. PubMed ID: 23764554
[TBL] [Abstract][Full Text] [Related]
32. Antifungals in the ICU.
Playford EG; Eggimann P; Calandra T
Curr Opin Infect Dis; 2008 Dec; 21(6):610-9. PubMed ID: 18978529
[TBL] [Abstract][Full Text] [Related]
33. ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patients.
Martin-Loeches I; Antonelli M; Cuenca-Estrella M; Dimopoulos G; Einav S; De Waele JJ; Garnacho-Montero J; Kanj SS; Machado FR; Montravers P; Sakr Y; Sanguinetti M; Timsit JF; Bassetti M
Intensive Care Med; 2019 Jun; 45(6):789-805. PubMed ID: 30911804
[TBL] [Abstract][Full Text] [Related]
34. Echinocandin use in the neonatal intensive care unit.
Caudle KE; Inger AG; Butler DR; Rogers PD
Ann Pharmacother; 2012 Jan; 46(1):108-16. PubMed ID: 22190252
[TBL] [Abstract][Full Text] [Related]
35. Invasive candidiasis and the utility of antifungal susceptibility testing in the ICU.
Coyle EA
J Pharm Pract; 2010 Feb; 23(1):33-7. PubMed ID: 21507791
[TBL] [Abstract][Full Text] [Related]
36. [Invasive fungal infection in solid organ transplant].
Gavaldà J; Meije Y; Len Ó; Pahissa A
Enferm Infecc Microbiol Clin; 2012 Dec; 30(10):645-53. PubMed ID: 23127517
[TBL] [Abstract][Full Text] [Related]
37. Invasive candidiasis in the intensive care unit.
Ostrosky-Zeichner L; Pappas PG
Crit Care Med; 2006 Mar; 34(3):857-63. PubMed ID: 16505666
[TBL] [Abstract][Full Text] [Related]
38. ÉPICO project. Development of educational recommendations using the DELPHI technique on invasive candidiasis in non-neutropenic critically ill adult patients.
Zaragoza R; Llinares P; Maseda E; Ferrer R; Rodríguez A;
Rev Esp Anestesiol Reanim; 2013; 60(7):e1-e18. PubMed ID: 23911095
[TBL] [Abstract][Full Text] [Related]
39. Best practice in treating infants and children with proven, probable or suspected invasive fungal infections.
Katragkou A; Roilides E
Curr Opin Infect Dis; 2011 Jun; 24(3):225-9. PubMed ID: 21455060
[TBL] [Abstract][Full Text] [Related]
40. Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and proposed epidemiological cutoff values.
Pfaller MA; Rhomberg PR; Messer SA; Jones RN; Castanheira M
Diagn Microbiol Infect Dis; 2015 Aug; 82(4):303-13. PubMed ID: 25986029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
